Given the previous reports indicating that WDR1 is a cytoskeleton-binding protein36–38 and considering the implications of the RNA-seq results, we suspected that GA-amide could inhibit glioma by affecting the binding of cytoskeleton-related proteins to WDR1. The gene discussed is WDR1; the disease is glioma.